Neovasc Inc. provides pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. Its products include the Neovasc Reducer, used to treat refractory angina, and the Tiara, which is under clinical investigation for the transcatheter treatment of mitral valve disease. The company earns revenue from the Reducer and offers email updates for interested parties.